{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:50:34Z","timestamp":1764784234331,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.mehy.2019.109267","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:46:58Z","timestamp":1559990818000},"page":"109267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches"],"prefix":"10.1016","volume":"130","author":[{"given":"Samira","family":"Bazmara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Shadmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Ghasemnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-071X","authenticated-orcid":false,"given":"Hossein","family":"Aghazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Pooshang Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12889-017-4111-4","article-title":"Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015","volume":"17","author":"Kyu","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mehy.2019.109267_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/604974","article-title":"Association of urban slum residency with infant mortality and child stunting in low and middle income countries","author":"Kyu","year":"2013","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.42.4.761","article-title":"Severe tetanus in immunized patients with high anti-tetanus titers","volume":"42","author":"Crone","year":"1992","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mehy.2019.109267_b0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.1986.03370090093029","article-title":"Clinical tetanus despite a'protective'level of toxin-neutralizing antibody","volume":"255","author":"Passen","year":"1986","journal-title":"JAMA"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2019.109267_b0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5694\/j.1326-5377.1986.tb113779.x","article-title":"Cephalic tetanus in an immunized patient. Clinical and electromyographic findings","volume":"145","author":"Vieira","year":"1986","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.mehy.2019.109267_b0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1978.03290080059029","article-title":"Tetanus despite preexisting antitetanus antibody","volume":"240","author":"Berger","year":"1978","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mehy.2019.109267_b0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S1473-3099(16)00075-X","article-title":"An unexpected tetanus case","volume":"16","author":"Ergonul","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00429-013-0697-1","article-title":"Structural and functional substrates of tetanus toxin in an animal model of temporal lobe epilepsy","volume":"220","author":"Ferecsk\u00f3","year":"2015","journal-title":"Brain Struct Funct"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0045","first-page":"57","article-title":"Tetanus and Clostridium tetani\u2013a brief review","volume":"38","author":"Stock","year":"2015","journal-title":"Med Monatsschr Pharm"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1476-4431.2006.00192.x","article-title":"Tetanus: pathophysiology, clinical signs, diagnosis, and update on new treatment modalities","volume":"16","author":"Linnenbrink","year":"2006","journal-title":"J Veterinary Emergency Crit Care"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4161\/hv.26769","article-title":"Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies","volume":"10","author":"Yousefi","year":"2014","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14573\/altex.1412181","article-title":"\u201cBINACLE\u201d assay for in vitro detection of active tetanus neurotoxin in toxoids","volume":"32","author":"Behrensdorf-Nicol","year":"2015","journal-title":"ALTEX"},{"year":"2011","series-title":"\u201cTetanus\u201d. Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Preventi","key":"10.1016\/j.mehy.2019.109267_b0065"},{"key":"10.1016\/j.mehy.2019.109267_b0070","unstructured":"Centers for Disease Control and Prevention. [Tetanus Surveillance \u2014 United States, 2001\u20132008]. Morbidity and Mortality Weekly Report.2011;60:[365\u201369]."},{"issue":"12","key":"10.1016\/j.mehy.2019.109267_b0075","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.3129","article-title":"Common variants associated with general and MMR vaccine\u2013related febrile seizures","volume":"46","author":"Feenstra","year":"2014","journal-title":"Nat Genet"},{"issue":"s3","key":"10.1016\/j.mehy.2019.109267_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1528-1167.2011.03032.x","article-title":"Vaccinations and febrile seizures","volume":"52","author":"Cendes","year":"2011","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pediatrneurol.2013.09.016","article-title":"Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian Study","volume":"50","author":"Zamponi","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"31","key":"10.1016\/j.mehy.2019.109267_b0090","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2015.06.009","article-title":"Risk of febrile seizure after measles\u2013mumps\u2013rubella\u2013varicella vaccine: a systematic review and meta-analysis","volume":"33","author":"Ma","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.2014-0690","article-title":"Etiologies for seizures around the time of vaccination","volume":"134","author":"Verbeek","year":"2014","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.mehy.2019.109267_b0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1528-1167.2011.03134.x","article-title":"A retrospective population-based study on seizures related to childhood vaccination","volume":"52","author":"von Spiczak","year":"2011","journal-title":"Epilepsia"},{"issue":"1\u20106","key":"10.1016\/j.mehy.2019.109267_b0105","first-page":"59","article-title":"Analysis of the immune response to papain digestion products of tetanus toxin","volume":"92","author":"Helting","year":"1984","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.mehy.2019.109267_b0110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1128\/iai.59.5.1627-1632.1991","article-title":"Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system","volume":"59","author":"Charles","year":"1991","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/nar\/gkg221","article-title":"Expression of tetanus toxin fragment C in tobacco chloroplasts","volume":"31","author":"Tregoning","year":"2003","journal-title":"Nucl Acids Res"},{"issue":"8","key":"10.1016\/j.mehy.2019.109267_b0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.phytochem.2004.03.004","article-title":"New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC","volume":"65","author":"Tregoning","year":"2004","journal-title":"Phytochemistry"},{"issue":"41","key":"10.1016\/j.mehy.2019.109267_b0125","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/j.vaccine.2010.08.016","article-title":"Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.mehy.2019.109267_b0130","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1016\/j.vaccine.2011.06.039","article-title":"Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate","volume":"29","author":"Yu","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.imbio.2010.09.001","article-title":"Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate","volume":"216","author":"Yu","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.mehy.2019.109267_b0140","first-page":"33","article-title":"Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy","volume":"106","author":"Haynes","year":"1993","journal-title":"Trans Assoc Am Phys"},{"year":"1995","series-title":"Analysis of HLA frequencies in population cohorts for design of HLA-based HIV vaccines. HIV Molecular Immunology Database","author":"Ward","key":"10.1016\/j.mehy.2019.109267_b0145"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humimm.2009.11.009","article-title":"Computational characterization of Plasmodium falciparum proteomic data for screening of potential vaccine candidates","volume":"71","author":"Singh","year":"2010","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109267_b0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/CVI.00051-14","article-title":"Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of Staphylococcus aureus skin and soft tissue infections","volume":"21","author":"Mocca","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/etm.2010.177","article-title":"Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2,-A3,-A11,-A24,-A31 and-A33)-positive patients with advanced cancer","volume":"2","author":"Yamada","year":"2011","journal-title":"Exp Therapeutic Med"},{"key":"10.1016\/j.mehy.2019.109267_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-8546-3_4","article-title":"Allele frequency net database","volume":"1802","author":"Gonzalez-Galarza","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109267_b0170","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/nar\/gky092","article-title":"UniProt: the universal protein knowledgebase","volume":"46","author":"The UniProt Consortium","year":"2018","journal-title":"Nucl Acids Res"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"issue":"13","key":"10.1016\/j.mehy.2019.109267_b0180","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.mehy.2019.109267_b0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0195","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jmb.2010.04.037","article-title":"Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells","volume":"399","author":"Li","year":"2010","journal-title":"J Mol Biol"},{"issue":"16","key":"10.1016\/j.mehy.2019.109267_b0200","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.mehy.2019.109267_b0205","unstructured":"Visualizer, Accelrys Discovery Studio. \u201cVersion 4.5.\u201d Software for visualizing and analyzing protein structures; 2017."},{"issue":"8","key":"10.1016\/j.mehy.2019.109267_b0210","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.00500-06","article-title":"Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines","volume":"74","author":"Qazi","year":"2006","journal-title":"Infect Immun"},{"issue":"28","key":"10.1016\/j.mehy.2019.109267_b0215","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1016\/j.vaccine.2009.03.084","article-title":"Generation of plant-derived recombinant DTP subunit vaccine","volume":"27","author":"Brodzik","year":"2009","journal-title":"Vaccine"},{"issue":"31\u201332","key":"10.1016\/j.mehy.2019.109267_b0220","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1016\/j.vaccine.2004.04.020","article-title":"Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC","volume":"22","author":"Stevenson","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0225","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3892\/mmr.2017.6227","article-title":"Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT\u2013Hc in mice","volume":"15","author":"Yang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0230","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1038\/s41598-017-08842-w","article-title":"Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach","volume":"7","author":"Khatoon","year":"2017","journal-title":"Sci Rep"},{"issue":"51","key":"10.1016\/j.mehy.2019.109267_b0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","article-title":"Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches","volume":"1","author":"Saadi","year":"2017","journal-title":"Infection, Genetics Evol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1039\/C6MB00772D","article-title":"Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches","volume":"13","author":"Nezafat","year":"2017","journal-title":"Mol BioSyst"},{"issue":"48","key":"10.1016\/j.mehy.2019.109267_b0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","article-title":"Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus","volume":"1","author":"Hajighahramani","year":"2017","journal-title":"Infection, Genetics Evol"},{"issue":"62","key":"10.1016\/j.mehy.2019.109267_b0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","article-title":"Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches","volume":"1","author":"Nezafat","year":"2016","journal-title":"Comput Biol Chem"},{"issue":"12","key":"10.1016\/j.mehy.2019.109267_b0255","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1080\/21645515.2017.1329788","article-title":"An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice","volume":"13","author":"Bounds","year":"2017","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"10","key":"10.1016\/j.mehy.2019.109267_b0260","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1089\/vim.2015.0060","article-title":"Identification of conserved peptides comprising multiple T cell epitopes of Matrix 1 protein in H1N1 influenza virus","volume":"28","author":"Lohia","year":"2015","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molimm.2014.04.009","article-title":"In silico predicted mycobacterial epitope elicits in vitro T-cell responses","volume":"61","author":"Khan","year":"2014","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.29252\/rmm.5.1.17","article-title":"A novel multi-epitope vaccine for cross protection against hepatitis C virus (HCV): an immunoinformatics approach","volume":"5","author":"Nosrati","year":"2017","journal-title":"Res Mol Med"},{"issue":"70","key":"10.1016\/j.mehy.2019.109267_b0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.compbiolchem.2017.08.016","article-title":"Development of an epitope-based vaccine inhibiting immune cells rolling and migration against atherosclerosis using in silico approaches","volume":"1","author":"Tourani","year":"2017","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.mehy.2019.109267_b0280","article-title":"Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides","volume":"26","author":"Castelli","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2019.109267_b0285","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjc.6603437","article-title":"Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I\/II study","volume":"95","author":"Bernhardt","year":"2006","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.mehy.2019.109267_b0290","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00262-006-0145-7","article-title":"Telomerase peptide vaccination: a phase I\/II study in patients with non-small cell lung cancer","volume":"55","author":"Brunsvig","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"10.1016\/j.mehy.2019.109267_b0295","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-11-1385","article-title":"Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I\/II trial","volume":"17","author":"Brunsvig","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.mehy.2019.109267_b0300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1078\/0171-2985-00286","article-title":"Epitope-vaccine strategy against HIV-1: today and tomorrow","volume":"208","author":"Liu","year":"2003","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.mehy.2019.109267_b0305","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/CVI.00492-07","article-title":"Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy","volume":"15","author":"Wilson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"22","key":"10.1016\/j.mehy.2019.109267_b0310","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1128\/JVI.01277-07","article-title":"Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape","volume":"81","author":"Liu","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109267_b0315","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.mehy.2019.109267_b0320","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/jvi.68.5.3334-3342.1994","article-title":"An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans","volume":"68","author":"Shirai","year":"1994","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.mehy.2019.109267_b0325","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00705-008-0082-1","article-title":"A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen","volume":"153","author":"Wei","year":"2008","journal-title":"Arch Virol"},{"key":"10.1016\/j.mehy.2019.109267_b0330","first-page":"2011","article-title":"Safety and immunogenicity of a human papillomavirus peptide vaccine (CIGB-228) in women with high-grade cervical intraepithelial neoplasia: first-in-human, proof-of-concept trial","volume":"24","author":"Solares","year":"2011","journal-title":"ISRN Obstetrics Gynecol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0335","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/IAI.00943-07","article-title":"A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis","volume":"76","author":"Zhu","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.171.1.299","article-title":"Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria","volume":"171","author":"Tam","year":"1990","journal-title":"J Exp Med"},{"issue":"17\u201318","key":"10.1016\/j.mehy.2019.109267_b0345","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","article-title":"Developing an epitope-driven tuberculosis (TB) vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.mehy.2019.109267_b0350","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2011.03.095","article-title":"Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs","volume":"29","author":"Tarradas","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/av_2011_01_61","article-title":"Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein","volume":"55","author":"Stanekova","year":"2011","journal-title":"Acta Virol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109267_b0360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-5793(93)80399-F","article-title":"New virus-specific T-helper epitopes of foot-and-mouth disease viral VP1 protein","volume":"333","author":"Volpina","year":"1993","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.mehy.2019.109267_b0365","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1001749","article-title":"A synthetic peptide vaccine directed against the 2\u03b22\u20132\u03b23 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax","volume":"185","author":"Oscherwitz","year":"2010","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.mehy.2019.109267_b0370","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1158\/1078-0432.CCR-11-0184","article-title":"Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients","volume":"17","author":"Kyte","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.mehy.2019.109267_b0375","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/j.1460-2075.1985.tb04086.x","article-title":"Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli","volume":"4","author":"Jacob","year":"1985","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0380","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol"},{"issue":"11","key":"10.1016\/j.mehy.2019.109267_b0385","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/fvl.12.108","article-title":"Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications","volume":"7","author":"Testa","year":"2012","journal-title":"Future Virol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109267_b0390","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1745-7580-6-S2-S1","article-title":"Computer aided selection of candidate vaccine antigens","volume":"6","author":"Flower","year":"2010","journal-title":"Immunome Res"},{"issue":"11","key":"10.1016\/j.mehy.2019.109267_b0395","first-page":"648","article-title":"Vaccines and autoimmunity. Nature Reviews","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Rheumatology"},{"issue":"9396","key":"10.1016\/j.mehy.2019.109267_b0400","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12026-016-8819-5","article-title":"Adjuvants-and vaccines-induced autoimmunity: animal models","volume":"65","author":"Ruiz","year":"2017","journal-title":"Immunol Res"},{"issue":"11","key":"10.1016\/j.mehy.2019.109267_b0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142563","article-title":"Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice","volume":"10","author":"Ghaffari-Nazari","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cas.12050","article-title":"Next-generation peptide vaccines for advanced cancer","volume":"104","author":"Yamada","year":"2013","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0420","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","article-title":"In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations","volume":"11","author":"Yang","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"12","key":"10.1016\/j.mehy.2019.109267_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083583","article-title":"Loss of multi-epitope specificity in memory CD4+ T cell responses to B. pertussis with age","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0430","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13071-015-0914-2","article-title":"Phlebotomus papatasi SP15: mRNA expression variability and amino acid sequence polymorphisms of field populations","volume":"8","author":"Ramalho-Ortig\u00e3o","year":"2015","journal-title":"Parasites Vectors"},{"issue":"7","key":"10.1016\/j.mehy.2019.109267_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040882","article-title":"Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10. 4, and Mtb72f via a bioinformatics approach","volume":"7","author":"Davila","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2019.109267_b0440","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/272950","article-title":"Designing peptide-based HIV vaccine for Chinese","volume":"2014","author":"Shu","year":"2014","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0445","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1073\/pnas.1314973111","article-title":"Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics","volume":"111","author":"Knudsen","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2019.109267_b0450","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9363750","article-title":"Computer-aided design of an epitope-based vaccine against Epstein-barr virus","volume":"2017","author":"Alonso-Padilla","year":"2017","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.mehy.2019.109267_b0455","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/irv.12513","article-title":"T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin","volume":"11","author":"Guti\u00e9rrez","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"10.1016\/j.mehy.2019.109267_b0460","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0465","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2009.10.103","article-title":"Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice","volume":"28","author":"Alexander","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.mehy.2019.109267_b0470","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","article-title":"Prototype Alzheimer\u2019s disease vaccine using the immunodominant B cell epitope from \u03b2-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide","volume":"174","author":"Agadjanyan","year":"2005","journal-title":"J Immunol"},{"issue":"9\u201312","key":"10.1016\/j.mehy.2019.109267_b0475","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03402131","volume":"9","author":"Iwai","year":"2003","journal-title":"Mol Med"},{"issue":"11","key":"10.1016\/j.mehy.2019.109267_b0480","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109267_b0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718309435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718309435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:37Z","timestamp":1759691797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718309435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":97,"alternative-id":["S0306987718309435"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109267","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109267"}}